These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Multiple-dose pharmacokinetics of imipramine and its major active and conjugated metabolites in depressed patients. Sutfin TA; Perini GI; Molnar G; Jusko WJ J Clin Psychopharmacol; 1988 Feb; 8(1):48-53. PubMed ID: 3350999 [TBL] [Abstract][Full Text] [Related]
4. Tricyclic antidepressant concentrations in plasma: an estimate of their sensitivity and specificity as a predictor of response. Perry PJ; Zeilmann C; Arndt S J Clin Psychopharmacol; 1994 Aug; 14(4):230-40. PubMed ID: 7962678 [TBL] [Abstract][Full Text] [Related]
5. Patterns of plasma imipramine-desipramine concentrations in patients receiving concomitant fluphenazine decanoate. Siris SG; Adan F; Lee A; Cooper TB; Mandeli J; Casey E J Clin Psychiatry; 1988 Feb; 49(2):64-5. PubMed ID: 3338977 [TBL] [Abstract][Full Text] [Related]
6. Imipramine and desipramine plasma levels: relationship to dosage schedule and sampling time. Ziegler VE; Biggs JT; Rosen SH; Meyer DA; Preskorn SH J Clin Psychiatry; 1978 Aug; 39(8):660-3. PubMed ID: 681303 [TBL] [Abstract][Full Text] [Related]
7. The influence of the route of administration of imipramine on imipramine and desipramine blood levels. Rigal J; Albin H; Fança X; Demotes-Mainard F; Vinçon G J Clin Psychopharmacol; 1989 Oct; 9(5):364-7. PubMed ID: 2677063 [TBL] [Abstract][Full Text] [Related]
8. Prediction of steady-state plasma levels of doxepin and imipramine from single dose levels in depressed outpatients. Hrdina PD; Bakish D; Swenson S; Lapierre YD J Psychiatry Neurosci; 1991 Mar; 16(1):25-9. PubMed ID: 2049367 [TBL] [Abstract][Full Text] [Related]
9. Effects of joint administration of imipramine and amantadine in patients with drug-resistant unipolar depression. Rogóz Z; Dziedzicka-Wasylewska M; Daniel WA; Wójcikowski J; Dudek D; Wróbel A; Zieba A Pol J Pharmacol; 2004; 56(6):735-42. PubMed ID: 15662086 [TBL] [Abstract][Full Text] [Related]
10. Depression in children: relationship between plasma imipramine levels and response. Preskorn SH; Weller EB; Weller RA J Clin Psychiatry; 1982 Nov; 43(11):450-3. PubMed ID: 7174621 [TBL] [Abstract][Full Text] [Related]
11. Alprazolam: an antidepressant? Alprazolam, desipramine, and an alprazolam-desipramine combination in the treatment of adult depressed outpatients. Fawcett J; Edwards JH; Kravitz HM; Jeffriess H J Clin Psychopharmacol; 1987 Oct; 7(5):295-310. PubMed ID: 3316312 [TBL] [Abstract][Full Text] [Related]
15. The relationship of plasma imipramine and N-desmethylimipramine to response in panic disorder. Mavissakalian MR; Perel JM Psychopharmacol Bull; 1996; 32(1):143-7. PubMed ID: 8927664 [TBL] [Abstract][Full Text] [Related]
17. Plasma concentrations of tricyclic antidepressants in clinical practice. Hollister LE J Clin Psychiatry; 1982 Feb; 43(2):66-9. PubMed ID: 7056706 [TBL] [Abstract][Full Text] [Related]
18. Excessive plasma concentration of tricyclic antidepressants resulting from usual doses: a report of six cases. Devane CL; Wolin RE; Rovere RA; Panahon NC; Sutfin TA; Jusko WJ J Clin Psychiatry; 1981 Apr; 42(4):143-7. PubMed ID: 7204359 [TBL] [Abstract][Full Text] [Related]
19. Possible nonlinear pharmacokinetics of desipramine after once daily dosing. Amsterdam JD; Brunswick DJ; Potter L; Rickels K Pharmacopsychiatry; 1986 Mar; 19(2):84-7. PubMed ID: 3703927 [TBL] [Abstract][Full Text] [Related]
20. Effect of metyrapone supplementation on imipramine therapy in patients with treatment-resistant unipolar depression. Rogóz Z; Skuza G; Wójcikowski J; Daniel WA; Wróbel A; Dudek D; Zieba A Pol J Pharmacol; 2004; 56(6):849-55. PubMed ID: 15662100 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]